MLYS R&D Expenses
Mineralys Therapeutics Inc · R&D Expenses
MLYS R&D Expenses
Latest reported$221.38Mperiod ending
MLYS Quarterly R&D Expenses ($6.62M → $221.38M)
Quarterly R&D Expenses
High-resolution chart · PNG
MLYS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 221,377,000 | |
| 24,365,000 | |
| 24,402,000 | |
| 31,450,000 | |
| 38,278,000 | |
| 37,879,000 | |
| 44,569,000 | |
| 53,985,000 | |
| 39,273,000 | |
| 30,754,000 | |
| 23,685,000 | |
| 22,499,000 | |
| 11,884,000 | |
| 12,293,000 | |
| 7,818,000 | |
| 6,059,000 | |
| 5,595,000 | |
| 6,778,000 | |
| 6,616,000 |